Identity
- Trade Name
- SUSVIMO FDA UDI
- Generic Name
- Ophthalmic needle, single-use FDA UDI
- Device Name
- SUSVIMO REFILL NEEDLE FDA UDI
- Model / Reference
- 4000100 FDA UDI
- Description
- SUSVIMO REFILL NEEDLE FDA UDI
Identifiers
- Catalog Number
- 4000100 FDA UDI
- Primary DI / UDI-DI
- 00810042590045 FDA UDI
- FDA Product Code
- FMI FDA UDI
- GMDN Term
- Ophthalmic needle, single-use FDA UDI
Classification
- Device Class
- Class II FDA UDI
- Regulation Number
- 880.5570 FDA UDI
- Commercial Distribution
- In Commercial Distribution FDA UDI
Clinical & Handling
Sterile
Yes
FDA UDI
Single Use
Yes
FDA UDI
Implantable
No
FDA UDI
Contains Latex
No
FDA UDI
Prescription Use
No
FDA UDI
Over-the-Counter
No
FDA UDI
Convenience Kit
No
FDA UDI
Combination Product
No
FDA UDI
HCT/P
No
FDA UDI
Premarket Exempt
No
FDA UDI
Lot / Batch Number
Yes
FDA UDI
Serial Number
No
FDA UDI
Expiration Date
Yes
FDA UDI
Manufacturing Date
No
FDA UDI
Category: Ophthalmic needle, single-use
Susvimo by Genentech, Inc. — Class II — FDA UDI — listed in FDA GUDID — regulatory data on deviCERTS
Similar devices
Also classified as Ophthalmic needle, single-use.
- Anodyne Surgical — Psi/Eye-Ko, Inc. · Class I
- Anaesthetic Needles — STERIMEDIX LIMITED · Class II
- Needle aspiration and injection — Katena Products, Inc. · Class I
- Anodyne Surgical — Psi/Eye-Ko, Inc. · Class I
- Anodyne Surgical — Psi/Eye-Ko, Inc. · Class I
- OMNI Edge Surgical System — Sight Sciences, Inc. · Class II
- Anodyne Surgical — Psi/Eye-Ko, Inc. · Class I
- Walcott Rx Products — Psi/Eye-Ko, Inc. · Class I
Authorization Coverage (1 country)
Regulatory Authorizations
United States Pending data
FDA UDI
| Source | Region | Type | Cert / Approval No. | Class | Status |
|---|---|---|---|---|---|
| FDA UDI | United States | FDA UDI | Registered in GUDID | Class II | Pending data |
Is this your device? Claim it to add documentation and request validation.
Manufacturer
- Manufacturer
- Genentech, Inc.
Sources (1)
- FDA UDI 2d9ee968-9ed1-4b2c-86cd-ec69fc6a40b3 35 fields · synced May 30, 2026